Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.34M Sell
11,143
-637
-5% -$73.5K 0.03% 325
2025
Q4
$1.24M Sell
11,780
-10,975
-48% -$1.03M 0.03% 317
2025
Q3
$1.91M Sell
22,755
-50,860
-69% -$4.19M 0.05% 299
2025
Q2
$5.83M Buy
73,615
+80
+0.1% +$6.36K 0.17% 155
2025
Q1
$6.6M Sell
73,535
-1,120
-2% -$105K 0.36% 64
2024
Q4
$7.43M Sell
74,655
-2,320
-3% -$239K 0.35% 64
2024
Q3
$8.74M Sell
76,975
-3,878
-5% -$461K 0.57% 58
2024
Q2
$10M Sell
80,853
-3,965
-5% -$511K 0.71% 44
2024
Q1
$11.2M Buy
84,818
+1,020
+1% +$126K 0.73% 43
2023
Q4
$9.14M Buy
83,798
+80,110
+2,172% +$8.32M 0.66% 46
2023
Q3
$380K Sell
3,688
-1,200
-25% -$129K 0.03% 122
2023
Q2
$564K Sell
4,888
-700
-13% -$79.5K 0.04% 120
2023
Q1
$595K Hold
5,588
0.05% 114
2022
Q4
$620K Hold
5,588
0.06% 110
2022
Q3
$481K Hold
5,588
0.05% 115
2022
Q2
$509K Buy
5,588
+300
+6% +$26.6K 0.05% 107
2022
Q1
$434K Hold
5,288
0.03% 117
2021
Q4
$405K Hold
5,288
0.03% 142
2021
Q3
$397K Hold
5,288
0.03% 138
2021
Q2
$411K Buy
+5,288
New +$393K 0.03% 142

Other funds holding MRK

CSM Advisors's MRK Position: Q1 2026 in Review

CSM Advisors reduced its Merck (MRK) stake by 5.4% in Q1 2026, selling an estimated $73.5K and leaving 11,143 shares worth $1.34M. The position accounts for 0.03% of the portfolio, ranked #325.

CSM Advisors first reported a position in MRK in Q2 2021 and has held it in 20 quarters since. The position peaked at $11.2M in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • CSM Advisors held 11,143 shares of Merck worth $1.34M as of Q1 2026.
  • CSM Advisors sold 637 Merck shares in Q1 2026, an estimated $73.5K.
  • Merck made up 0.03% of CSM Advisors's portfolio in Q1 2026, its #325 holding.
  • CSM Advisors first reported a position in Merck in Q2 2021 and has held it in 20 quarters since.
  • CSM Advisors's Merck position peaked at $11.2M in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on CSM Advisors's 13F filing for Q1 2026, filed 15 May 2026.